Collegium Pharmaceutical Inc (COLL)
29.96
-0.45
(-1.48%)
USD |
NASDAQ |
Nov 22, 16:00
29.92
-0.04
(-0.13%)
After-Hours: 20:00
Collegium Pharmaceutical Market Cap: 966.22M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 966.22M |
| November 21, 2024 | 980.73M |
| November 20, 2024 | 967.51M |
| November 19, 2024 | 959.44M |
| November 18, 2024 | 942.35M |
| November 15, 2024 | 953.96M |
| November 14, 2024 | 976.21M |
| November 13, 2024 | 973.31M |
| November 12, 2024 | 1.013B |
| November 11, 2024 | 1.038B |
| November 08, 2024 | 1.037B |
| November 07, 2024 | 1.119B |
| November 06, 2024 | 1.113B |
| November 05, 2024 | 1.078B |
| November 04, 2024 | 1.055B |
| November 01, 2024 | 1.079B |
| October 31, 2024 | 1.101B |
| October 30, 2024 | 1.117B |
| October 29, 2024 | 1.136B |
| October 28, 2024 | 1.132B |
| October 25, 2024 | 1.118B |
| October 24, 2024 | 1.106B |
| October 23, 2024 | 1.157B |
| October 22, 2024 | 1.166B |
| October 21, 2024 | 1.175B |
| Date | Value |
|---|---|
| October 18, 2024 | 1.239B |
| October 17, 2024 | 1.255B |
| October 16, 2024 | 1.268B |
| October 15, 2024 | 1.242B |
| October 14, 2024 | 1.225B |
| October 11, 2024 | 1.216B |
| October 10, 2024 | 1.181B |
| October 09, 2024 | 1.211B |
| October 08, 2024 | 1.225B |
| October 07, 2024 | 1.283B |
| October 04, 2024 | 1.349B |
| October 03, 2024 | 1.286B |
| October 02, 2024 | 1.264B |
| October 01, 2024 | 1.280B |
| September 30, 2024 | 1.245B |
| September 27, 2024 | 1.232B |
| September 26, 2024 | 1.239B |
| September 25, 2024 | 1.205B |
| September 24, 2024 | 1.217B |
| September 23, 2024 | 1.231B |
| September 20, 2024 | 1.259B |
| September 19, 2024 | 1.254B |
| September 18, 2024 | 1.249B |
| September 17, 2024 | 1.204B |
| September 16, 2024 | 1.195B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
475.91M
Minimum
Mar 18 2020
1.349B
Maximum
Oct 04 2024
794.51M
Average
753.94M
Median
Market Cap Benchmarks
| Amicus Therapeutics Inc | 2.886B |
| Insmed Inc | 13.09B |
| Pulmonx Corp | 268.12M |
| RxSight Inc | 1.807B |
| Context Therapeutics Inc | 104.25M |
Market Cap Related Metrics
| PE Ratio | 12.86 |
| PS Ratio | 2.296 |
| PEG Ratio | 0.0088 |
| Price to Book Value | 4.124 |
| Price to Free Cash Flow | 7.150 |
| Price | 29.96 |
| Earnings Yield | 7.78% |
| PEGY Ratio | 0.0088 |
| Operating PE Ratio | 7.111 |
| Normalized PE Ratio | 11.93 |